TYRA News

The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. Tech consultancy Thoughtworks (TWKS) raised $774 million at a $7.0 billion market cap. This agile software developer...read more

Tyra Biosciences, a preclinical biotech developing FGFR kinase inhibitors for solid tumors, raised $173 million by offering 10.8 million shares at $16, the high end of the range of $14 to $16. The company offered 1.8 million more shares than anticipated. It originally planned to offer 6.7 million shares before increasing the offering to 9 million shares on Tuesday. Tyra Biosciences...read more

Tyra Biosciences, a preclinical biotech developing FGFR kinase inhibitors for solid tumors, raised the proposed deal size for its upcoming IPO on Tuesday. The Carlsbad, CA-based company now plans to raise $135 million by offering 9 million shares at a price range of $14 to $16. The company had previously filed to offer 6.7 million shares at the same range. At the revised deal size,...read more

Updated Monday, 9/13. After a wave of launches in the short holiday week, 11 IPOs are scheduled to raise over $3 billion in the week ahead. Tech consultancy Thoughtworks (TWKS) plans to raise $700 million at a $6.3 billion market cap. This agile software developer provides premium, end-to-end digital strategy, design, and engineering services to more...read more